BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/11/2024 10:58:28 AM | Browse: 379 | Download: 1251
Publication Name World Journal of Gastroenterology
Manuscript ID 92303
Country Italy
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Translational Research
Article Title Overlapping approach PPIs/Nux vomica-Heel as new intervention model in the management of GERD: A Delphi consensus study
Manuscript Source Unsolicited Manuscript
All Author List Edda Battaglia, Luciano Bertolusso, Marco Del Prete, Marco Monzani and Marco Astegiano
ORCID
Author(s) ORCID Number
Edda Battaglia http://orcid.org/0000-0002-0670-9120
Funding Agency and Grant Number
Funding Agency Grant Number
Guna S.p.a. (unconditional granted)
Corresponding Author Edda Battaglia, MD, Director, Director, Gastroenterology Unit, ASLTO4, Ivrea, Piazza Credenza 2, Turin 10034, Italy. edda.battaglia@gmail.com
Key Words Gastro-esophageal reflux disease; Proton pump inhibitors; Consensus; Nux vomica-heel; Overlapping; Decalage
Core Tip This Delphi consensus suggests Nux vomica-Heel as a new therapeutic tool for the Medical Doctor (MD) who daily finds himself diagnosing and treating Gastro-Esophageal Reflux Disease (GERD). Nux vomica-Heel is multicomponent/multitarget low dose medication that can be introduced in the patient's therapeutic plan in overlapping with Proton Pump Inhibitors (PPIs) to progressively reduce the use of PPIs through an appropriate decalage plan. All the statements were approved with a large majority by a panel of gastroenterologists, otolaryngologists, geriatrics, and general practitioners expert in GERD, demonstrating their validity and the importance of the topic covered by the consensus.
Publish Date 2024-05-11 10:58
Citation

Battaglia E, Bertolusso L, Del Prete M, Monzani M, Astegiano M. Overlapping approach PPIs/Nux vomica-Heel as new intervention model in the management of GERD: A Delphi consensus study. World J Gastroenterol 2024; 30(18): 2467-2478

URL https://www.wjgnet.com/1007-9327/full/v30/i18/2467.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i18.2467
Full Article (PDF) WJG-30-2467-with-cover.pdf